Axsome Therapeutics, Inc. (AXSM)
|52 Week Range||53.71-91.29|
|1y Target Est||-|
|DCF Unlevered||AXSM DCF ->|
|DCF Levered||AXSM LDCF ->|
|Debt / Equity||68.86%||Buy|
Upgrades & Downgrades
Latest AXSM news
3 Biotech Stocks That Could Be Millionaire Makers
22 November 2023
There are several paths to millionaire status, and investing is one of them. But to give yourself a chance to become a millionaire this way, it's important to buy a diverse basket of solid companies a...
3 Growth Stocks to Buy Right Now Without Any Hesitation
11 November 2023
AbbVie looks like a bargain that has stronger growth on the way. Axsome Therapeutics is in the early innings of what could be an exciting growth story.
Axsome (AXSM) Q3 Loss Widens, Revenues Surpass Estimates
7 November 2023
Axsome (AXSM) incurs a wider-than-expected loss in the third quarter of 2023 while sales beat estimates. The company's shares declined post earnings announcement.
Riding the Wave: 3 Stocks That Can 10X by 2025
30 October 2023
It's the dream of every investor to uncover stocks with the potential to grow tenfold within a short span. While it may sound like a lofty goal, the article reveals that it's not just a pipe dream.
Analysts Estimate Axsome Therapeutics (AXSM) to Report a Decline in Earnings: What to Look Out for
30 October 2023
Axsome (AXSM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Axsome Update: Buy At Dips And Hold Forever
16 October 2023
Axsome Therapeutics' Auvelity is experiencing strong sales growth in the Major Depressive Disorder space, with sales of $27.6 million in the last quarter. Auvelity offers rapid onset of symptom improv...
Axsome Therapeutics to Report Third Quarter 2023 Financial Results on November 6
10 October 2023
Axsome to host conference call and webcast on Monday, Nov. 6, 2023, at 8:00 a.m. Eastern Time Axsome to host conference call and webcast on Monday, Nov. 6, 2023, at 8:00 a.m. Eastern Time
2 Top Biotech Stocks to Buy in October
3 October 2023
Vertex Pharmaceuticals is awaiting a regulatory decision on what may become its next blockbuster. Axsome Therapeutics aims to launch several products over the next few years.
Why Is Axsome (AXSM) Up 8.6% Since Last Earnings Report?
6 September 2023
Axsome (AXSM) reported earnings 30 days ago. What's next for the stock?